Editorial team
ioQuanta Research Desk
-
Evidence date ·Why the way carbon nanotubes connect changes what a polymer can do
Review or Meta-AnalysisA 2021 review explains how amino coating helped nanotubes disperse and form conductive paths in epoxy at 0.13% by weight; untreated tubes needed 0.51%.
-
Evidence date ·Could a whole tumor vaccine help the immune system recognize more of glioblastoma?
Review or Meta-AnalysisFor glioblastoma, a 2021 review proposes using irradiated tumor cells to help the immune system recognize more targets. The main results came from colon cancer mice.
-
Evidence date ·Why ready-made donor cells may not keep blood cancers in check
Review or Meta-AnalysisA 2021 review describes early donor natural killer cell trials and an investigational bank, showing the appeal of faster supply and the challenge of keeping cells active.
-
Evidence date ·A patterned backing increased an antenna’s measured gain and lowered absorption in a tissue simulation
PreprintA slotted wearable antenna worked in two Wi-Fi bands; its patterned backing raised measured gain while simulated tissue absorption fell.
-
Evidence date ·A milled dental restoration has more than one job
Review or Meta-AnalysisA 2021 review compares ceramic, composite and hybrid blocks for milled dental restorations, showing why strength alone cannot settle the choice for a crown or inlay.
-
Evidence date ·A pain crisis and fever after treatment for advanced melanoma
Review or Meta-AnalysisAfter nivolumab and ipilimumab, a woman with widespread melanoma developed severe pain, fever and a serious inflammatory syndrome, making the source of her symptoms difficult to untangle.
-
Evidence date ·How tiny carriers could change where cancer immune treatment acts
Review or Meta-AnalysisA 2021 review describes carriers that hold antibodies near tumors or deliver vaccine cargo to immune cells, while patient benefit remains unproven.
-
Evidence date ·Why might blocking EZH2, a gene-silencing enzyme, need a cancer drug partner?
Review or Meta-AnalysisA 2021 review contrasts tazemetostat’s approved use with uneven responses and model studies where EZH2 blockade both aided immune recognition and favored immune-suppressing cells.
-
Evidence date ·What does pressure leave behind after it kills tumor cells?
Review or Meta-AnalysisResearchers used pressure to kill tumor cells while preserving material dendritic cells could collect. The vaccine findings came from laboratory and animal studies.
-
Evidence date ·Why a tumor’s surroundings may shape whether a virus can fight it
Review or Meta-AnalysisA 2021 review explains how fibroblasts can hinder viral spread in tumors and cites an early glioma study reporting durable responses in 20% of patients.